E-drug: USA penalizes Argentina for patent issues
-------------------------------------------------
The official recision of Argentina's GSP benefits because of its refusal
to cave to U.S. demands on pharmaceutical patent and testing policy.
Robert Weissman
Essential Information | Internet: rob@essential.org